Florida suit challenges Gotham Green’s stake in two medical marijuana licenses

MJBizCon 2023 tickets are now on sale! Discover the business solutions to elevate your cannabis retail game. Buy your ticket today.

A cannabis investor sued Florida regulators for allegedly approving a request by private equity firm Gotham Green Partners to have ownership positions in two vertically integrated medical marijuana licenses in the state.

Investor Michael Weisser and medical cannabis patient advocates filed the suit Friday in the state’s 2nd Judicial Court in Tallahassee, according to Politico.

The lawsuit cited the state’s medical marijuana law that prohibits an individual or entity from “directly or indirectly” having an ownership stake greater than 5% in more than one license.

The Florida Office of Medical Marijuana Use granted a variance to Gotham Green that allows the New York-based investment firm to own more than 5% of iAnthus Capital Holdings and MedMen Enterprises licenses, according to Politico.

“This is such a blatant violation of the regulations, it’s unbelievable,” Weisser told Politico. “(The regulators) just want to sweep it under the table.”

New York-based iAnthus has 18 MMJ dispensaries in Florida under the GrowHealthy brand. Los Angeles-headquartered MedMen has seven dispensaries in Florida, according to the state’s most recent weekly update.

Business leaders need reliable industry data and in-depth analysis to make smart investments and informed decisions in these uncertain economic times.

Get your 2023 MJBiz Factbook now!

Featured Inside:
  • 200+ pages and 50 charts with key data points
  • State-by-state guide to regulations, taxes & opportunities
  • Segmented research reports for the marijuana + hemp industries
  • Accurate financial forecasts + investment trends


Stay ahead of the curve and avoid costly missteps in the rapidly evolving cannabis industry.

New York-based Gotham Green has been seeking to take control of iAnthus after the company defaulted on its debt and was forced to reorganize its finances under Canadian court supervision.

Weisser also claimed in the lawsuit that state regulators thwarted his efforts to obtain documents about the variance through public-record requests.